Aim: Although higher adiponectin levels predict a low risk of type 2 diabetes, elevated adiponectin levels predict higher mortality in older persons. Methods: We examined the associations of adiponectin with anthropometric, metabolic and hematological variables and renal function in 361 community-dwelling elderly women aged 76±8. Renal function was assessed using the estimated glomerular filtration rate (eGFR). 
has been inconsistent 5) . Although a protective association has been documented in younger adults without prevalent CVD 6) , this has not been reproduced in groups with manifest heart disease 7, 8) or in older adults 5) , where the relationship has in fact been directionally opposite. This paradoxical adverse association of higher levels of adiponectin with CVD morbidity and mortality in older adults has been replicated in different settings [9] [10] [11] , but its basis remains unclear. Anemia of any degree is recognized as a significant independent contributor to morbidity, mortality, and frailty in elderly people 12, 13) . Anemia is common, albeit not severe, in the older population, and a substantial proportion of anemia is of indeterminate cause 14) . Chronic kidney disease (CKD) is also com-36.5%, respectively) were reported to be receiving statins, anti-diabetic and anti-hypertensive drugs, respectively. Drug information was not available in group A. Body mass index was calculated by height and weight, and body fat was measured using an impedance method (InBody 430; Biospace, Tokyo, Japan). Serum total and HDL cholesterol were assayed as previously reported 17, 18) . Adiponectin was assayed by a sandwich enzyme-linked immunosorbent assay (Otsuka Pharmaceutical Co., Ltd., Tokushima City, Japan). Intra-and inter-assay CV were 3.3% and 7.5%, respectively. Leptin was assessed by a RIA kit from LINCO research (St. Charles, MO, interassay CV = 4.9%). Complete blood cell count was analyzed using an automated blood cell counter (Sysmex XE-2100; Sysmex, Kobe, Japan).
Serum creatinine was measured enzymatically using an Autoanalyzer (AU 5200; Olympus, Tokyo, Japan) in all women in both groups A and B. Cystatin C was measured by latex immunoassay using a commercially available kit (IatroCys-C; Mitsubishi Chemical Medience, Tokyo, Japan) in 159 elderly women in group B. The estimated glomerular filtration rate (eGFR) was calculated using the equation recommon in the older population 15) and has recently been reported to be associated with mortality regardless of age across a wide range of populations 16) . Therefore, we examined whether adiponectin levels are associated with hemoglobin and kidney function in elderly women.
Subjects and Methods
A total of 361 elderly women were recruited as volunteers by local welfare commissioners from the city of Nishinomiya, Hyogo, Japan. Elderly women comprised 2 groups of community-dwelling people. One group consisted of 202 elderly women who participated in 2007, 2008 and 2009 (group A) . Another group consisted of 159 women who participated in 2011 (group B). The study was approved by the Ethics Committees of MWU and written informed consent was obtained from all participants.
Anthropometric indices were measured after an overnight fast in group B, and between breakfast and lunch in group A. Thereafter, blood samples were obtained from the cubital vein. Of 159 women in group B, 43, 9 and 58 women (27.0%, 5.7%, and hsCRP, and positively with HDL cholesterol. In addition, adiponectin was related inversely to cystatin C-based as well as creatinine-based eGFR, although there was no association with serum creatinine and cystatin C levels.
In stepwise multiple regression analysis including the percentage body fat, serum leptin, HDL cholesterol, creatinine-based eGFR and hemoglobin as independent variables ( Table 2 , model 1), hemoglobin and creatinine-based eGFR emerged as determinants of adiponectin independent of HDL cholesterol and percentage body fat. When cystatin C-based eGFR was included instead of creatinine-based eGFR (model 2), hemoglobin and cystatin C-based eGFR were independently associated with adiponectin. When cystatin C-based and creatinine-based eGFR were included in the same model (model 3) the former emerged as an independent determinant of adiponectin. In these models, approximately 30% of adiponectin variability was explained by these 4 variables. Including the usage of drugs in the model hardly changed the results (data not shown).
In the same 3 models as in Table 2 , from which 29 subjects were excluded who were in CKD G3b and G4 according to creatinine-based eGFR, the association between adiponectin and hemoglobin remained significant independent of metabolic variables, whereas neither creatinine-based nor cystatin C-based eGFR emerged as determinants of adiponectin (data not shown).
Using the World Health Organization definition (hemoglobin ＜12 g/dL), 79 of 316 women (25.0%) were diagnosed as having anemia. Elderly women with anemia had higher serum adiponectin and prevalence of CKD G3b＋4 than those without anemia ( where Cr and Cys-C are serum creatinine in mg/ dL and cystatin C in mg/L, respectively, and eGFRcreat and eGFRcys are creatinine-based and cystatin-C-based eGFR, respectively. CKD was diagnosed using the guidelines of the National Kidney Foundation Kidney Disease Outcome Quality Initiative 21) . Data are presented as the mean±SD unless otherwise stated. Due to deviation from normal distribution, hsCRP was logarithmic transformed for analysis. Differences between 2 groups were analyzed by the t test and frequencies of conditions by Chi-square tests. Differences among 3 groups were analyzed using analysis of variance. When p values in analysis of variance were p＜0.05, Bonferroni's multiple comparison procedure was performed. Correlations of adiponectin were evaluated by Pearson correlation analysis.
Stepwise multiple regression analyses were performed to further indentify the most significant variables contributing to the variation of adiponectin. Potential confounders were forced into the model and standardized β coefficients were calculated. The explanatory power of the model was expressed as adjusted R 2 values. A two-tailed p＜0.05 was considered statistically significant. All calculations were performed with SPSS system 15.0 (SPSS Inc., Chicago, IL). Table 1 , elderly women were nonobese, rather slim and normoglycemic. Creatininebased eGFR (eGFRcreat) was substantially lower than cystatin C-based eGFR (eGFRcys). Consequently, the prevalence of CKD (eGFR ＜60 mL/min/1.73 m 2 ) was markedly higher using creatinine-based than cystatin C-based eGFR (38.8% vs. 5.5%). Using eGFRcreat, 30.7% (111/361) and 8.0% (n = 29/361) of women were diagnosed as having CKD G3a (eGFR ≥ 45−＜60 mL/min/1.73 m 2 ) and 3b＋4 (eGFR ＜45 mL/min/1.73 m 2 ), respectively. The respective prevalence was 3.6% (n = 13/159) and 1.9% (n = 7/159) when CKD was diagnosed using eGFRcys.
Results

As shown in
Adiponectin was positively associated with age and inversely with serum albumin, red blood cell count, hemoglobin ( Fig. 1) and hematocrit ( Table 1) . It was negatively associated with BMI, percentage body fat, nonHDL-cholesterol, serum leptin and log tin than those with CKD G3a and G1＋2 (Fig. 2) . However, using cystatin C-based eGFR, there was no significant difference in adiponectin concentrations among women with G1＋2 (n = 139), G3a (n = 13) and G3b＋4 (n = 7) (15.6±7.3, 18.9±9.0 and 14.3± 3.7 μg/dL, respectively, p = 0.262). This might be due however, there was no difference in the prevalence of CKD G3a between the 2 groups. The prevalence of CKD using eGFRcreat was slightly higher in the present study (38.8%) than in Japanese women in their 70s (31.3%) 20) . Women with creatinine-based CKD G3b＋4 had higher adiponec- Mean±SD or n (%). The number in parenthesis is the number of women studied. CKD: chronic kidney disease, G3, G3a, G3b and G4: CKD stage G3 (eGFR＜60), G3a (eGFR≦45-＜60), G3b (eGFR≦30-＜45) and G4 (eGFR＜30), respectively, where the unit of eGFR is mL/min/1.73 m 2 . See text for details. Other abbreviations are the same as in Table 1 . Table 1 . The number of women studied for eGFRcys and other variables was 159 and 361, respectively. lesterol in non-obese, elderly women, as previously reported in patients with type 2 diabetes 23) and those with coronary artery disease 24) . Circulating adiponectin levels have been shown to be elevated in patients (see Ref. 25) with, and in a mouse model of, end-stage kidney disease 26) , at least in part due to the low clearance rate. However, studies linking adiponectin and renal function have been conducted in persons with existing disorders such as CKD, diabetes and coronary disease and the results were inconsistent and contradictory [27] [28] [29] [30] [31] [32] . To our knowledge, there are four studies linking adiponectin and renal function in healthy persons [33] [34] [35] [36] and again, the results were inconsistent and contradictory. In the current study of healthy elderly women, eGFR, regardless of the method to estimate GFR, was inversely associated with serum adiponectin. An inverse association was reported in Japanese 33) , and South 34) and West Africans 35) , with no association in Caucasians 34) . In contrast, there was a positive association between eGFR and high molecular weight adiponectin in healthy Japanese people with eGFR ≥ 60 mL/min/1.73 m 2 , whereas no significant association was found in those with eGFR ＜60 mL/min/1.73 m 2 36) . Further studies are needed to clarify the relationship between serum adiponectin and kidney function.
Although serum creatinine is used routinely in assessing GFR, the impact of muscle mass on serum creatinine makes interpretation difficult, especially in elderly individuals 37) . Serum cystatin C has been shown to be more reliable and superior to creatinine in the detection of renal impairment 38) . In the present study, cystatin C-based eGFR emerged as an independent predictor of adiponectin when both cystatin C-based and creatinine-based eGFR were included in the same multiple regression model.
Higher interval changes in adiponectin were positively associated with total and cardiovascular mortality in the elderly population 39) . The leading explanation is that these increases occur in response to homeostatic dysregulation and serve as a marker of such dysregulation 39) . Adiponectin levels were greater in centenarians and their offspring than in unrelated elderly people [2] [3] [4] . Given the association of adiponectin-raising polymorphisms with exceptional longevity 4) , it is likely that increases in adiponectin later in life represent unsuccessful attempts to compensate for age-related homeostatic decline 39) . Several limitations must be acknowledged. The cross-sectional design did not allow a causal relationship. The recruitment procedure may also have had some potential impact on the results. As participation was voluntary, women who pay more attention to in part to the small sample size.
Discussion
The current study demonstrates that blood hemoglobin and eGFR, regardless of the method used to estimate GFR, are independently associated with adiponectin in community-living elderly women. These associations remained significant after adjustment for anthropometric and metabolic determinants of adiponectin, including fat mass, serum leptin and HDL cholesterol. We confirmed the previous findings that high adiponectin is associated with a more favorable CVD risk profile [1] [2] [3] [4] and demonstrated that it is associated with more advanced kidney disease with lower GFR and a higher degree of anemia.
Higher adiponectin levels predict a low risk of type 2 diabetes 1) , but predict higher mortality in older persons 5, [9] [10] [11] . The present findings suggest that anemia and renal dysfunction are important and independent confounders of elevated circulating adiponectin in elderly women. Few studies have examined associations between plasma adiponectin concentration and hemoglobin or anemia [22] [23] [24] . Matsubara et al. 22) found an inverse association between adiponectin and red blood cell counts in healthy Japanese women aged from 20 to 74 years old; however, they did not report the association in separate age groups. We found inverse associations between adiponectin and hemoglobin and extrapolated that the association was independent of kidney function, body fat and HDL cho- Biochemical parameters were measured only once. We did not have detailed drug information. Both thiazolidinediones and renin-angiotensin-system inhibitors had effects on adiponectin as well as hemoglobin levels 39, 40) . More than half of the study participants were lacking drug information, so the possible contribution of these drugs to adiponectin levels or other parameters could not be completely excluded. Finally, we did not measure B-type natriuretic peptide (BNP), a reliable marker of heart failure 41) . In addition to anemia and CKD, chronic heart failure is common in the elderly and has been shown to be associated with elevated serum adiponectin 7) . We conclude that hemoglobin and eGFR are independently predictive of serum adiponectin in community-dwelling elderly women. Anemia and reduced renal function may contribute to elevated adiponectin levels in the elderly, and may represent important confounders of the relationship between elevated adiponectin and mortality in this population.
